Contact
Print
Urology & Nephrology
PSI is a leading full-service CRO operating globally.
98% of PSI-managed clinical trials complete patient enrollment on or ahead of schedule.
PSI's exceptional repeat and referral business rate distinguishes PSI in the market place as a "no-nonsense" CRO that delivers across trials of all sizes and levels of complexity.
PSI has successfully performed Phase II/III studies in the following urology and nephrology indications:
- Benign prostatic hyperplasia
- Bladder malignancies
- Chronic kidney disease
- Chronic prostatitis
- Diabetic nephropathy
- Prostate cancer
- Pyelonephritis
- Renal anemia
- Renal carcinoma
- Renal insufficiency/failure
- Renal replacement therapy
- Hemodialysis
- Peritoneal dialysis - Urinary incontinence/Overactive bladder
- UTI (cystitis, urethritis)
PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including internists, medical oncologists, gynecologists, urologists, and dialysis specialists.